PDSB - PDS Biotechnology Corp P/S Multiple

Brandmark of pdsbiotech.com (PDSB)

Demand for innovative medicines provides the asset with crisis resilience, which GURU.Markets captured as a sharp spike in the fundamental P/S ratio for PDS Biotechnology (PDSB). is the current value of this metric, while the business's success is based on the efficiency of the Versamune platform. At the same time, the lack of recurring revenue makes PDS Biotechnology (PDSB) dependent on external financing and the results of clinical trials.

PDSB (PDS Biotechnology) Price-to-Revenue Ratio history from 07/04/2022 to 11/13/2026

PDS Biotechnology (PDSB) - metric breakdowns and financial figures

- market price and analyst price targets:
Stock Quotes pdsbiotech.com|PDSB - Consensus Target
- market capitalization statistics:
Market Capitalization PDS Biotechnology Corp|PDSB - Total Company Value
- balance sheet equity data:
Equity per Share PDS Biotechnology|PDSB - Company Book Value|Market-to-Book Ratio pdsbiotech.com|PDSB - Cumulative Company Assets
- issuer credit burden and liquidity indicators:
Debt to Capital Ratio PDS Biotechnology|PDSB - Long-Term Debt to Equity Ratio|Short-Term Loans to Capital Ratio pdsbiotech.com|PDSB - Company Aggregate Debts|Debt to Net Assets Ratio PDS Biotechnology Corp|PDSB - Company Long-Term Debts|Short-Term Debt PDS Biotechnology|Intermediate Coverage Ratio pdsbiotech.com
- net income and valuation multiples indicators:
PDSB - Net Profit|Projected Future Earnings PDS Biotechnology|PDSB - Price to Earnings Ratio|Price to Expected Earnings Ratio pdsbiotech.com|PDSB - Price/Earnings to Growth Multiple|Company Value to EBITDA PDS Biotechnology Corp|PDSB - Profit before payment of interest, taxes and amortization|Earnings per one share for the last 12 months PDS Biotechnology|PDSB - Net earnings per share (EPS TTM)|Year-over-year earnings per share growth for the last 12 months pdsbiotech.com|PDSB - Earnings per share growth in current year|Consensus forecast of earnings per share growth for next year PDS Biotechnology
- total revenue and sales volume data:
PDSB - Company Sales|Company Future Revenue pdsbiotech.com|PDSB - P/S Multiple|Price-to-Projected Revenue Ratio PDS Biotechnology Corp
General company analysis:PDS Biotech, PDSB
Manufactured product of PDS Biotechnology Corp

PDS Biotechnology (PDSB) maintains stability through a fully staffed R&D core and high loyalty among leading immunologists. This intellectual capital drives revenue potential, which, within the P/S metric, correlates with market capitalization. The ratio measures the cost of each unit of sales, reflecting the market's recognition of business management efficiency. By analyzing price-to-sales dynamics on GURU.Markets, an investor can distinguish a sustainable growth trend from short-term speculative fluctuations.

Competing companies

Market Cap to Revenue immunitybio.com IBRX|Immunocore - Market Cap to Revenue|P/S Multiple Janux Therapeutics Inc JANX|RCUS - Price-to-Revenue Ratio|ZYME (Zymeworks Biopharmaceuticals) - Market Cap to Revenue Ratio|Tango Therapeutics (TNGX) - Price-to-Revenue Ratio|Price to Sales iovance.com (IOVA)|Market Cap to Revenue IMTX|XNCR - Price-to-Revenue Multiple|Market Cap to Revenue CMPX (Compass Bio)|Market Cap to Sales Volume REPL|P/S Multiple LYEL (Lyell Immunopharma)|Market Capitalization-to-Revenue Ratio IPHA|Pyxis - P/S Multiple|Price to Sales Compugen Ltd.|IO Biotech Corp (IOBT) - Price-to-Revenue Ratio|Sutro Biopharma, Inc - Market Capitalization-to-Revenue Ratio|INKT (MiNK Therapeutics, Inc.) - P/S Multiple|P/S Multiple Werewolf|Price-to-Revenue Ratio Immix Biopharma, Inc. (IMMX)|ALXO: Price-to-Sales Ratio|Cue Biopharma, Inc. - Market Cap to Revenue|Sonnet BioTherapeutics Holdings, Inc. (SONN) - Price to Sales|MAIA - Price-to-Revenue Ratio|Price-to-Sales Ratio LIMN|LVTX: P/S Multiple|Market Cap to Revenue Ratio NXTC|Price-to-Revenue Ratio Leap Therapeutics Inc|Intensity Tx (INTS) - Price-to-Revenue Coefficient|Market Cap to Revenue SNSE (Sensei Biotherapeutics)|TOVX (therivabio.com) - Market Capitalization-to-Revenue Ratio|P/S Multiple GRTS (Gritstone bio)|Kineta Inc - Price-to-Revenue Ratio|NexImmune Corp - P/S Multiple|Price-to-Revenue Coefficient Turnstone Biologics TSBX|Vaccinex, Inc. (VCNX) - Price-to-Revenue Ratio|Price to Sales harpoontx.com (HARP)